by andre | Jul 27, 2026 | KoreFeed
SARCOMATRIX THERAPEUTICS CORP. FOR IMMEDIATE RELEASE Sarcomatrix Applies SarcoVista™ Translational Modeling to First-in-Human Dose Selection for S-969 The preclinical-stage company is using its proprietary modeling platform to inform the starting dose and escalation...
by andre | Jul 23, 2026 | KoreFeed
RENO, Nev., July 24, 2026 (KOREWIRE) … Sarcomatrix Therapeutics Corp., a Delaware corporation based in Reno, Nevada, today announced that its investment round is open to accredited investors. The round is being conducted under Regulation D, Rule 506(c), and is...
by andre | Jul 22, 2026 | KoreFeed
NEWPORT BEACH, Calif., July 22, 2026 (KOREWIRE)— ICON Capital Group, LLC (“ICON”), a boutique investment banking and capital markets advisory firm, today announced the successful completion of a Regulation Crowdfunding (Reg CF) capital raise for IllumiCell...
by andre | Jul 17, 2026 | KoreFeed
ORLANDO, Fla. — July 17, 2026 (KOREWIRE)— Tokenova Worldwide, Inc. (“Tokenova Worldwide” or the “Company”), a capital infrastructure enterprise focused on supporting critical technology companies through regulated capital markets, digital...
by andre | Jul 16, 2026 | KoreFeed
Company Submits Comprehensive Recommendations to Chairman Paul Atkins for the SEC’s 2026–2030 Strategic Plan TORONTO, ON – July 16, 2026 [KOREWIRE] – KoreInside today announced that it has formally submitted a comprehensive comment letter to U.S....
